Cellular Biomedicine Group, Inc. announced that Bosun S. Hau resigned as a director. The Board elected Darren Michael O'Brien, Sailing Capital’s nominee, as a non-executive Class III director of the Company to fill the vacancy created by Mr. Hau’s departure. Mr. O’Brien was also elected to serve as a member of each of the Compensation Committee and Nominating and Corporate Governance Committee. From May 2013 to the present, Mr. O'Brien has served as Executive Director at Sailing Capital (Hong Kong).